Correlation Between NYSE Composite and Phoenix Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Phoenix Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Phoenix Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Phoenix Biotech Acquisition, you can compare the effects of market volatilities on NYSE Composite and Phoenix Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Phoenix Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Phoenix Biotech.

Diversification Opportunities for NYSE Composite and Phoenix Biotech

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between NYSE and Phoenix is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Phoenix Biotech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phoenix Biotech Acqu and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Phoenix Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phoenix Biotech Acqu has no effect on the direction of NYSE Composite i.e., NYSE Composite and Phoenix Biotech go up and down completely randomly.
    Optimize

Pair Corralation between NYSE Composite and Phoenix Biotech

Assuming the 90 days trading horizon NYSE Composite is expected to generate 1.6 times more return on investment than Phoenix Biotech. However, NYSE Composite is 1.6 times more volatile than Phoenix Biotech Acquisition. It trades about 0.07 of its potential returns per unit of risk. Phoenix Biotech Acquisition is currently generating about 0.1 per unit of risk. If you would invest  1,518,431  in NYSE Composite on September 20, 2024 and sell it today you would earn a total of  380,265  from holding NYSE Composite or generate 25.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy28.28%
ValuesDaily Returns

NYSE Composite  vs.  Phoenix Biotech Acquisition

 Performance 
       Timeline  

NYSE Composite and Phoenix Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Phoenix Biotech Acquisition

Pair trading matchups for Phoenix Biotech

Pair Trading with NYSE Composite and Phoenix Biotech

The main advantage of trading using opposite NYSE Composite and Phoenix Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Phoenix Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phoenix Biotech will offset losses from the drop in Phoenix Biotech's long position.
The idea behind NYSE Composite and Phoenix Biotech Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Correlations
Find global opportunities by holding instruments from different markets
CEOs Directory
Screen CEOs from public companies around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance